<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">

        <!-- Favicon.ico -->
        <link rel="apple-touch-icon" sizes="180x180" href="Assets/favicon/apple-touch-icon.png">
        <link rel="icon" type="image/png" sizes="32x32" href="Assets/favicon/favicon-32x32.png">
        <link rel="icon" type="image/png" sizes="16x16" href="Assets/favicon/favicon-16x16.png">

        <!-- Main styling -->
        <link rel="stylesheet" href="style.css">

        <!-- Bootstrap -->
        <link type="text/css" rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@5.2.2/dist/css/bootstrap.min.css">
        <script type="text/javascript" src="https://cdn.jsdelivr.net/npm/bootstrap@5.2.2/dist/js/bootstrap.bundle.min.js"></script>

        <!-- OverlayScrollbars -->
        <link rel="stylesheet" href="libraries/OverlayScrollbars Source/OverlayScrollbars.min.css">
        <script src="libraries/OverlayScrollbars Source/OverlayScrollbars.min.js"></script>

        <!-- Title -->
        <title>Health and Policy - Blog</title>
    </head>

    <body>
        <!-- Navbar -->
        <nav class="navbar navbar-expand-lg bg-light fixed-top" style="max-height: 8vh">
            <div class="container-fluid">
                <a class="navbar-brand" href="index.html"><svg id="logo-35" width="40" height="31" viewBox="0 0 50 39" fill="none" xmlns="http://www.w3.org/2000/svg"> <path d="M16.4992 2H37.5808L22.0816 24.9729H1L16.4992 2Z" class="ccompli1" fill="#007AFF"></path> <path d="M17.4224 27.102L11.4192 36H33.5008L49 13.0271H32.7024L23.2064 27.102H17.4224Z" class="ccustom" fill="#312ECB"></path></svg><span style="margin-left: 1vw; font-size: 1.2rem;" class="logo-text">Health and Policy</span></a>
                <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
                    <span class="navbar-toggler-icon" onclick="toggleSidebarDisplay()"></span>
                </button>
                <div class="collapse navbar-collapse" id="navbarNav">
                    <ul class="navbar-nav" style="margin-left: auto !important">
                        <li class="nav-item">
                            <a class="nav-link active" aria-current="page" href="index.html">Home</a>
                        </li>
                        <li class="nav-item dropdown">
                            <a class="nav-link dropdown-toggle" href="#" role="button" data-bs-toggle="dropdown" aria-expanded="false">
                                Sections
                            </a>
                            <ul class="dropdown-menu">
                                <li><a class="dropdown-item checked" id="all" href="">All <span id="all-check">&#10003</span></a></li>
                                <li><a class="dropdown-item" id="course-required" href="">Course-required <span id="course-required-check"></span></a></li>
                                <li><a class="dropdown-item" id="technology" href="">Technology <span id="technology-check"></span></a></li>
                                <li><a class="dropdown-item" id="policy" href="">Policy <span id="policy-check"></span></a></li>
                                <li><a class="dropdown-item" id="research-notes" href="">Research Notes <span id="research-notes-check"></span></a></li>
                                <li><a class="dropdown-item" id="ethics" href="">Ethics <span id="ethics-check"></span></a></li>
                            </ul>
                        </li>          
                        <li class="nav-item">
                            <a class="nav-link" href="works-cited.html">Works Cited</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link" href="attribution.html">Attribution</a>
                        </li>
                    </ul>
                </div>
            </div>
        </nav>

        <div class="content row"> 
            <div class="col-3"></div>
            <div class="col" id="articles">

                <article class="course-required policy">
                    <div class="img-wrap">
                        <img class="article-image rounded" src="Assets/1949_food_guide.gif" alt="An image of a Canadian food guide from 1949. The heading reads in bold text 'Canada's Food Rules'">
                    </div>
                    <h1 class="title">Public Health and Nutrition Policy</h1>
                    <h6 class="date">18th of January</h6>
                    <h4 id="name">Luca Donais</h4>
                    <p style="margin-top: 3vh;">
                        An extremely long-running challenge in public health is the difficulty of promoting proper nutrition in a way that is effective and acceptable to the general population. This is a pressing concern for a few reasons; most notably, improper nutrition (be it undernutrition, obesity, or micronutrient deficiency), is very strongly correlated with negative health outcomes, including type 2 diabetes, some forms of cardiovascular disease, certain types of cancer, and osteoarthritis, among others.<sup><a href="works-cited.html#70">[70]</a></sup> For the government, additional concerns are also significant, including the cost of improper nutrition to the health care system; estimates have placed the cost of obesity alone to the health care system at between 4.6 and 7.1 billion Canadian dollars.<sup><a href="works-cited.html#70">[70]</a></sup> When accounted for alongside other nutrition-related diseases, as well as the significant societal costs of excess death and productivity loss, the societal cost of improper nutrition is very difficult to measure but can be assumed to be extremely high. With that being said, however, the topic of nutrition policy has very little research into it. The field of public health in general is, of course, chronically underfunded; however, literature covering policy options for improving nutrition is unusually sparse for an issue of such immediate cost to institutions and society. 
                        <br><br>
                        However, in the existing literature, there is some agreement on what makes effective public policy for nutrition. Unfortunately, the general agreement tends not to agree with the policies most commonly undertaken by governments, most likely because the interventions that are least effective also tend to be the most palatable to the public and the food industry - and thus require the least political capital - such as communications campaigns. There are a number of challenges to the establishment of effective public policy on nutrition, many of which are relatively intractable under our current systems of economy and political power. 
                        <br><br>
                        One of the primary challenges to effective public policy in this area is the simple fact that people often like things that aren‚Äôt good for them, and resist change that might make those things harder to access. In addition, citizens in liberal democracies have a tendency to be very attached to the concept of freedom, and strongly resist public policy that is viewed as coercive, no matter how well-founded it may be.<sup><a href="works-cited.html#76">[76]</a></sup> Another very important challenge in this area is the influence of lobbyists in the food industry; food industry lobbying is very powerful, especially relating to nutrition policy.<sup><a href="works-cited.html#73">[73]</a></sup> (A slightly less diplomatic way of expressing that concept is to say that politicians don't tend to support policies that would harm the food industry becase the food industry frequently hands them large sacks with dollar signs scrawled on the side). In addition, as the food industry employs many people across Canada, politicians have the additional incentive to avoid harming the industry and causing job losses. However, the food industry, while a significant stakeholder when it comes to nutrition policy, has a fairly clear conflict of interest; their fiduciary duty to stakeholders means they are arguably legally required to act in the interests of making as much money as possible.<sup><a href="works-cited.html#79">[79]</a></sup> Therefore, they clearly do not have the best interests of Canadians in mind. A decent comparison would be allowing tobacco companies to spend millions of dollars lobbying against cigarette and vaping regulations - which we in fact do continue to allow as well.<sup><a href="works-cited.html#83">[83, 84]</a></sup>
                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/nestle.jpg" alt="The logo of the global food and beverage company Nestl√©."><br>
                                <figcaption class="figure-caption">Food and beverage companies like Nestl√© routinely spend hundreds of<br>thousands of dollars in lobbying for their interests.<sup><a href="works-cited.html#80">[80]</a></sup></figcaption>
                            </figure>
                        </div>
                        With that in mind, let‚Äôs have a look at a few examples of nutrition policy that could be implemented by a hypothetical government, and examine their effectiveness and the challenges that our hypothetical government may face when implementing such strategies. We‚Äôll cover them in order from (in my opinion) least to most coercive. 
                        <br><br>
                        The first strategy is also the most common; understandably, since it‚Äôs the one with the least barrier to entry. This is public health communications campaigns like the Canadian Food Guide and the Canadian Healthy Eating Strategy (though the latter includes other strategies).<sup><a href="works-cited.html#77">[77]</a></sup> This is often championed through the school system, for two primary reasons. The first is because changes to the curriculum are cheap, compared to advertising; and the second is that small children are malleable. If you can convince the children to eat more healthily, odds are pretty good that that habit will stick around to adulthood. Strengths of such a policy more broadly are primarily in palatability; since it‚Äôs the least coercive of the reasonable options, it‚Äôs very likely to be accepted by the general population and by food industry lobbying groups.<sup><a href="works-cited.html#81">[81]</a></sup> In addition, if effective, they can prompt the food industry to refocus on healthier foods, if consumers take the advice on board and start buying healthier foods. However, the downsides are many. These campaigns are very costly and have shown limited effectiveness, considering they have been attempted globally for decades and rates of obesity and other nutrition-related diseases continue to rise.<sup><a href="works-cited.html#70">[70]</a></sup> Considering the extremely mixed evidence for their consistent effectiveness, they can perhaps be considered a useful tool, but only when combined with other interventions that are more borne out by the evidence.
                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/obesity-graph.png" alt="A graph showing rates of obesity among OECD countries. The trend in the graph is upwards."><br>
                                <figcaption class="figure-caption">A graph showing rates of obesity among OECD countries.<sup><a href="works-cited.html#80">[80]</a></sup></figcaption>
                            </figure>
                        </div>
                        The next candidate for our hypothetical country is food labeling standards. Canada has implemented this strategy quite extensively as well, as evidenced by the food labels on the backs of most of what we buy nowadays. This strategy can be, in a sense, thought of as an extension of the last strategy, as it relates to communication with the customer to try to encourage them to make healthier choices by giving them more information and education about how to eat well. This approach has a few strengths, including incentivizing the industry to reduce levels of potentially harmful ingredients in food such as sodium, trans fat, and sugar.<sup><a href="works-cited.html#81">[81]</a></sup> However, it relies on the consumer to be motivated enough to bother reading and understanding label information, and evidence is mixed on whether it actually significantly affects consumer behavior. Once again, it is a valuable tool; especially for those particularly motivated to eat healthily or those who need to avoid eating too much of certain nutrients, such as pregnant people and those with some diseases.<sup><a href="works-cited.html#81">[81]</a></sup>
                        <br><br>
                        The next strategy I‚Äôd like to cover is the use of financial incentives and disincentives applied by the government. These could come in the form of soda or junk food taxes, subsidies for fruits and vegetables, or agricultural incentives to increase production. These have a number of strengths, including the fact that cost plays a major role in peoples‚Äô purchasing decisions; of course, something that is less expensive is going to be more attractive, and if the cost of something increases, consumers are likely to look for substitute goods. In addition, lowering the cost of healthy options makes it significantly easier for low-income Canadians to get their hands on healthy foods, as healthy alternatives are often unable to compete with cheaper and more plentiful processed foods.<sup><a href="works-cited.html#81">[81]</a></sup> However, this approach also comes with significant disadvantages. First and foremost is its cost - if improperly balanced, incentives can cost significant amounts to the taxpayer, as the government has to pay for subsidies (though that saving is passed on to the consumer). The other side of that coin, however, is that too many disincentives with too few incentives can raise the price of food, causing prices to rise for the consumer; this has the double effect of worsening food insecurity and being incredibly unpopular. In addition, this approach is often strongly disfavored by the food industry, as it is viewed as costly government interference in the free market, and thus it is typically significantly lobbied against.<sup><a href="works-cited.html#81">[81]</a></sup> In addition, it can be unpopular with consumers, making it politically challenging. However, when properly balanced, this strategy has been demonstrated to have beneficial effects on consumers‚Äô purchasing behavior.<sup><a href="works-cited.html#69">[69]</a></sup>
                        <br><br>
                        Lastly, our hypothetical government could consider food marketing standards. These typically consist of restrictions on how and when certain food products can be marketed, and are typically geared towards reducing the marketing of high-sugar and -sodium foods to children.<sup><a href="works-cited.html#81">[81]</a></sup> This is primarily because children are particularly susceptible to food marketing, as they are largely unable to psychologically differentiate between advertising and regular programming. In addition, as previously discussed, attitudes formed in childhood tend to remain strong for extended periods of time.<sup><a href="works-cited.html#81">[81]</a></sup> This approach is supported by many health-related organizations, including the World Health Organization.<sup><a href="works-cited.html#72">[72]</a></sup> It has the advantage of being low-cost, as the government doesn‚Äôt need to do much, save for passing legislation and enforcing it. In addition, this approach has shown some evidence of effectiveness in the past,<sup><a href="works-cited.html#75">[75]</a></sup> though research is relatively limited. However, this approach is extremely strongly opposed by the food and advertising industries, as it stands to lose them massive amounts of money. Additionally, there are concerns about the coerciveness of this approach, and questions about whether it‚Äôs the government‚Äôs role to govern what people should and shouldn‚Äôt see, especially if the regulations aren‚Äôt confined to only children.<sup><a href="works-cited.html#75">[75]</a></sup> 
                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/cereal_aisle.jpg" alt="A cereal aisle in Islamabad."><br>
                                <figcaption class="figure-caption">Marketing of unhealthy foods is often directed towards children.</figcaption>
                            </figure>
                        </div>
                        In the end, nutrition is a very complicated topic, and one that‚Äôs tough to talk about. Despite its significant health impacts, it‚Äôs a far-away problem for many, as most of us don‚Äôt spend our lives thinking about heart disease whenever we break into a burger. That being said - maybe we should? There are significant societal and individual harms associated with poor nutrition, and the current dearth of literature and research on the topic isn‚Äôt making it any easier to find solutions that work for as many people as possible. Perhaps it‚Äôs time to start thinking not just about the way the food we eat affects us, but how we, as a society, can work to improve our system of nutrition for everyone. 
                        <br><br>
                        The last one was a bit glum, so I‚Äôm glad I found myself a topic I could put a hopeful spin on. That being said, thanks for reading! I‚Äôll see you next time (if there is a next time),
                        <br><br>
                        Luca.

                    </p>
                    
                    <hr>
                </article>

                <article class="course-required ethics">
                    <div class="img-wrap">
                        <img class="article-image rounded" src="Assets/wakefield_protest.webp" alt="Former doctor Andrew Wakefield standing in front of a crowd of people holding signs at an anti-vaccine protest. One of the signs reads in part 'We're with Wakefield'.">
                    </div>
                    <h1 class="title">How Andrew Wakefield Caused a Vaccine Scare for Money</h1>
                    <h6 class="date">5th of January</h6>
                    <h4 id="name">Luca Donais</h4>
                    <p style="margin-top: 3vh;">
                        On the 28th of February, 1998, Andrew Wakefield published an early report in the Lancet, a prestigious medical journal, claiming a link between the MMR vaccine, a new bowel disease, and autism. This report, shared with a room full of British journalists at a press conference shortly after its publication,<sup><a href="works-cited.html#61">[61]</a></sup> sparked intense debate in the UK at the time, sparking the modern anti-vaccine movement - first in the UK, then around the world. However, the paper has some issues, of which much has been made since its publication. In addition to the issues with the paper, there are also issues with the author - Wakefield was mired in a minefield of ethical, legal, and financial entanglements, ultimately leading to his being struck off from the UK General Medical Council register<sup><a href="works-cited.html#67">[67]</a></sup>, having his medical license stripped away, and being disgraced in (most of) the public eye. 
                        <br><br>
                        All that being said, for most, this paper has now faded from memory. Many of us have a vague recollection of the movement being based on one discredited and retracted paper, and some may even know who wrote it, but for the most part it is no longer a major cultural artifact. Those for whom it continues to be, however‚Äîincluding Wakefield himself, who continues to wage his antivax crusade in the United States, having been publicly humiliated in the UK<sup><a href="works-cited.html#59">[59]</a></sup>‚Äîcontinue to snub vaccination and spread their ideas, driving vaccination rates downwards. This, not coincidentally, has coincided with a significant rise in cases of dangerous infectious diseases like measles.<sup><a href="works-cited.html#66">[66]</a></sup> However, this is not the whole story. This saga is far more interesting than it has any right to be‚Äîbecause simply knowing Wakefield‚Äôs report as a paper that was wrong and retracted diminishes it greatly. There is so much more to the dumpsterfire that is this paper than can be expressed in such a simple explanation, and I am <em>so</em> excited to explain why. 

                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/wapo_measles_graph.png" alt="A graph, sourced to the Washington Post, showing measles cases in the United States by year. The title states 'Measles cases hit a record in 2019.'"><br>
                                <figcaption class="figure-caption">More measles is bad, or so it has been explained to me.</figcaption>
                            </figure>
                        </div>

                        I‚Äôm not going to linger too long on what is presented in the paper itself; not because it‚Äôs not interesting and rife with inaccuracies in its own right, but rather because the motivations and incentives surrounding its publication tell a far better story. However, it‚Äôs worth mentioning, leading into a discussion of its context, that the paper itself is nonsense. Details given by parents of at least two of the anonymized children who participated in the study align with none of the records in the paper Three of the nine children who were reported to have regressive autism did not have autism diagnoses at all, and only one of them ‚Äúclearly had regressive autism.‚Äù<sup><a href="works-cited.html#61">[61]</a></sup> Many of the conclusions surrounding autism in the paper are framed as repetition of the parents opinions: for instance, ‚ÄúOnset of behavioural symptoms was associated, <em>by the parents</em>, with measles, mumps, and rubella vaccination in eight of the 12 children [...].‚Äù<sup><a href="works-cited.html#68">[68]</a></sup> There are far more issues to be found in the paper, but as that is not the focus of this post, we will have to move on. 
                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/RETRACTED.png" alt="The first page of Wakefield's report. The word RETRACTED is plastered in bright red across the page."><br>
                                <figcaption class="figure-caption">The study is so retracted that it's physically hard to read.</figcaption>
                            </figure>
                        </div>
                        That leads us to an important question, however. What would drive someone to do this? Wakefield was a surgeon and researcher<sup><a href="works-cited.html#61">[61]</a></sup> before all of this‚Äîhe went to medical school‚Äîso of course he would have known, at the very least, that sweeping conclusions should not be drawn from a pilot study with such a small sample size. So then why would he go forward with it, going so far as to stage a press conference, ensuring that his findings would be plastered across the media and the public consciousness for decades to come? 
                        <br><br>
                        The answer, as it often is, is money. Wakefield was mired in several financial entanglements surrounding the MMR vaccine scare, none of which he was eager to disclose. The first is his relationship with an attorney named Richard Barr, who paid him an undisclosed ¬£150 (adjusted for inflation, almost 450 Canadian dollars) per hour, plus expenses, for his research.<sup><a href="works-cited.html#61">[61]</a></sup> In the two years Wakefield was on Barr‚Äôs payroll, he gained ¬£435 643‚Äîmore than 1.2 million Canadian dollars today.<sup><a href="works-cited.html#61">[61]</a></sup> Why would Barr pay such a ludicrous amount of money? He was preparing for a class-action lawsuit against MMR manufacturers on behalf of parents of autistic children‚Äîa lawsuit that would have been extremely profitable to him personally.<sup><a href="works-cited.html#61">[61]</a></sup>
                        <br><br>
                        It is worth noting Wakefield did not initially come out against vaccines in general; he only came out against the combined MMR vaccine, advocating for the use of monovalent (separate) measles, mumps, and rubella vaccines.<sup><a href="works-cited.html#62">[62]</a></sup> This was an odd stance to take, since his argument was that measles virus could gather in the gut, causing a bowel disorder that he called autistic enterocolitis (AE), that progressed to autism. He gave no explanation as to why a single vaccine would be any different.<sup><a href="works-cited.html#61">[61]</a></sup> However, we can infer his motivations from his behavior, as shortly before publishing his research, he filed patents both for testing kits for AE and a monovalent measles vaccine.<sup><a href="works-cited.html#62">[62]</a></sup> Both of these patents stood to make him huge sums of money if his research was accurate‚Äîor at least, if he could convince enough people that it was. He also became director of several companies, including Immunospecifics Biotechnologies Ltd and Carmel Healthcare Ltd, which would play parts in these ventures.<sup><a href="works-cited.html#62">[62]</a></sup> 
                        <br><br>
                        Wakefield was already pitching himself and these businesses to investors. In a 35 page ‚Äúprivate and confidential‚Äù prospectus‚Äîobtained by a journalist‚Äîwhose goal was to raise ¬£700 000 (~$1.9 million today) from investors, he claimed ‚ÄúIt is estimated that by year 3, income from this testing could be about ¬£3,300,000 rising to about ¬£28,000,000 (~$9 million to ~$79 million) as diagnostic testing in support of therapeutic regimes come on stream.‚Äù<sup><a href="works-cited.html#63">[63]</a></sup> In a separate document, titled ‚ÄúInventor/school/investor meeting 1.‚Äù, he predicted an annual turnover in Britain and America of ¬£72.5 million (~$205 million) for testing kits for AE. ‚ÄúIn view of the unique services offered by the Company and its technology, particularly for the molecular diagnostic,‚Äù it is written in the document, ‚Äúthe assays can command premium prices.‚Äù<sup><a href="works-cited.html#62">[62]</a></sup> None of these conflicts of interest were reported to the Lancet, the journal that published his report, and they were a major reason for his being struck off from the UK General Medical Council (GMC) register in 2010, following the longest fitness to practice hearing in the organization‚Äôs history.
                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/GMC Logo.jpg" alt="The UK General Medical Council Logo, which reads 'General Medical Council: Regulating doctors / Ensuring good practice'."><br>
                                <figcaption class="figure-caption">The UK General Medical Council Logo</figcaption>
                            </figure>
                        </div>
                        To delve into his financial entanglements leaves aside his ethical ones, however. There are too many to list here, so as a taster: at a speech to the Mind Institute in California, Wakefield described one of his son‚Äôs birthday parties, at which he claims‚Äîto audience laughter‚Äîthat he lined up the children (32 of them, aged between 4 and 9), and offered them ¬£5 each for their blood.<sup><a href="works-cited.html#60">[60, 64]</a></sup> That is to say, he gave children money in exchange for their blood so that he could use it in scientific research. This was obviously not cleared by an ethics committee, and was deeply unethical on its face. He claimed that when he did this, two children fainted and one threw up over his mother. When questioned about this during his GMC hearing, he claimed that those details had been made up; though, predictably, admitting to being a liar did little to ingratiate them to him.<sup><a href="works-cited.html#64">[64]</a></sup>
                    </p>
                    <blockquote>
                        ‚ÄúAnd (NAME) burst into tears. Ruined his birthday party.  But people said to me, Andrew, look, you know, you can‚Äôt do this, people, children won‚Äôt come back to you. [laughter]. I said you‚Äôre wrong, I said: ‚ÄòListen, we live in a market economy. Next year they‚Äôll want ten pounds!'‚Äù
                        <br><br>
                        ‚ÄîWakefield, at a speech to the Mind Institute in California<sup><a href="works-cited.html#60">[60]</a></sup>
                    </blockquote>
                    <p>
                        In the summer of 2022, I was in Qu√©bec City, walking past the National Assembly on Grande-All√©e, and I saw a small group of demonstrators in front of the building, protesting vaccination. Several had signs claiming their supposed link to autism. For me, for a long time, this issue was very abstract. I didn‚Äôt know any anti-vaxxers, and so their beliefs were easy to square away, to think of as a fringe minority. Forgettable, inconsequential, irrelevant. But that moment reminded me that the people who oppose vaccination are human beings, intelligent and rational, if misled. Their beliefs have real consequences, and cause real harm. Those signs that the protesters were holding, decrying vaccines as causing autism‚Äîhis name may not have been on them, but they are a consequence of the scare that Wakefield created so that he could get rich.
                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/quebec_parliament.jpg" alt="A photo of the Parliament Building of Quebec."><br>
                                <figcaption class="figure-caption">The National Assembly (l'Assembl√©e Nationale) building in Quebec City.</figcaption>
                            </figure>
                        </div>
                        I hope that money was worth it to him. I hope he‚Äôs happy. Because those who have caught preventable diseases due to his misinformation; their loved ones; hell, even those people on that sweltering day in Qu√©bec City, misled into fearing the benign, driven to put themselves and others at risk and probably cut off relationships with people they care about due to a difference in belief‚Äîthat is to say, the predictable collateral damage of Wakefield‚Äôs scheme‚Äîthey certainly are not.
                        <br><br>
                        This one turned out darker than I expected, but important. Thank you for reading, and as always, I'll see you next time,
                        <br><br>
                        Luca.
                    </p>
                    
                    <hr>
                </article>

                <article class="course-required ethics policy">
                    <h1 class="title">Biotech Ethics</h1>
                    <h6 class="date">29th of November, 2022</h6>
                    <h4 id="name">Luca Donais</h4>
                    <p style="margin-top: 3vh;">
                        Hi there! It's been a while. I've been hard at work on something big, new, and fancy, which you can find <a href="./biotech-ethics/main.html">here</a>! I decided to go rather overboard, mostly because I was bored on the instructional support days (though it ended up taking way longer than those two days - whoopsie). This has, of course, delayed work on the last research notes post about pulse oximetry - that is still in the works, and should (in theory) show up soon. 
                        <br><br>
                        This newest post is about ethics in biotechnology, a sticky subject with great importance in the world today. In it, I cover in some depth the ethical issues involved with both human genetic editing and human genetic modification. At around 3300 words, it's one of the longest things I've ever written; if I had to guess, maybe third or fourth. It was a bit of an endeavor to put together, but I found it completely fascinating all the way through. Even now, there are more arguments, points, and modifications that continue to come to mind, and I'm having to restrain myself from muddling my point any further by adding more content. 
                        <br><br>
                        All that is a long-winded way of saying that I really enjoyed putting this together, and I really hope you enjoy reading it!
                        <br><br>
                        See you next time,
                        <br><br>
                        Luca.
                    </p>
                    <p>P.S. If you're curious, the source code for this website can be found on github, <a href="https://github.com/ludon5681/health-and-policy" target="_blank">here</a>. The specific files for this post can be found under the biotech-ethics folder - the .html files are the main content of the post, and the .js and .css files which are in the src subfolder of biotech-ethics control styling and interactive behaviours.</p>
                    
                    <hr>
                </article>

                <article class="research-notes technology">
                    <div class="img-wrap">
                        <img class="article-image rounded" src="Assets/light-finger.jpg" alt="An image of a doctor using a pulse oximeter device on a patient.">
                    </div>
                    <h1 class="title">Research Notes 2: Pulse Oximeter Function and Flaws</h1>
                    <h6 class="date">17th of October, 2022</h6>
                    <h4 id="name">Luca Donais</h4>
                    <p style="margin-top: 3vh;">
                        To be more precise from the last research notes, pulse oximeters are sensors that use light to measure the concentration of oxyhemoglobin (hemoglobin that is oxygenated) in the blood, as compared to deoxyhemoglobin (hemoglobin that is deoxygenated).<sup><a href="works-cited.html#14">[14]</a></sup> In principle, that is not very difficult to do; Beer-Lambert‚Äôs law, a formula for determining the absorbance of a mixture of solute and solvent (in this case, hemoglobin in blood) to a given wavelength of light, can be rearranged to solve for the concentration (C) of a given solute within a solvent, given the light path length (d), a measure of the distance that light travels, which is different from the physical distance that the light travels due to refraction<sup><a href="works-cited.html#15">[15]</a></sup>; the absorbance (ùõº) of the solution, or the quantity of light that is absorbed by the solution; and the extinction coefficient (ùúñ) of the solute, which is the light absorption of the solute at a given wavelength.<sup><a href="works-cited.html#14">[14]</a></sup><br>

                        <div class="formula-container">
                            <div class="formula-container">
                                <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" width="164.51248741149902" height="43.20000076293945" style="width:164.51248741149902px;height:43.20000076293945px;font-family:Asana-Math, Asana;background:#FFF;"><g><g><g><g transform="matrix(1,0,0,1,2,27.399993896484375)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M400 -16C446 -16 513 54 545 84L545 97L532 97C513 79 489 55 462 55C417 55 424 184 424 216C474 278 520 343 558 413C551 428 544 444 536 459L525 459C511 391 456 315 420 257C422 336 445 472 332 473C164 473 27 243 24 93C23 33 43 -16 111 -16C203 -16 297 64 357 131C357 96 348 -15 400 -16ZM284 437C371 437 358 224 357 164C314 113 233 28 162 28C109 28 98 70 99 115C100 202 175 437 284 437Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,21.4375,27.399993896484375)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M604 347L604 406L65 406L65 347ZM604 134L604 193L65 193L65 134Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,37.89996337890625,27.399993896484375)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M732 722L720 733C668 707 632 698 560 691L556 670L604 670C628 670 638 663 638 646C638 638 637 629 636 622L608 468C578 477 551 482 526 482C457 482 363 410 317 323C286 265 266 170 266 86C266 21 281 -11 310 -11C337 -11 374 6 408 33C462 77 495 116 562 217L539 126C528 82 523 50 523 24C523 3 532 -9 549 -9C566 -9 590 3 624 28L705 88L695 107L651 76C637 66 621 59 612 59C604 59 598 68 598 82C598 90 599 99 606 128ZM363 59C347 59 338 73 338 98C338 224 384 380 433 418C446 428 465 433 492 433C536 433 565 427 598 410L586 351C549 171 408 59 363 59ZM793 284C793 90 900 -18 1091 -18C1187 -18 1258 5 1348 67C1348 67 1358 103 1358 103C1358 103 1348 110 1348 110C1254 53 1202 35 1124 35C967 35 881 131 881 309C881 447 938 653 1166 653C1237 653 1289 639 1345 603L1345 519L1372 519C1377 576 1385 619 1399 665C1323 694 1266 706 1204 706C1024 706 793 578 793 284ZM1767 222C1777 251 1783 268 1782 263C1703 261 1626 262 1548 262C1567 349 1622 438 1722 438C1782 438 1804 420 1831 369L1851 369L1892 422C1717 592 1448 361 1448 155C1448 42 1514 -11 1621 -11C1698 -11 1762 47 1821 92L1821 111C1774 78 1718 39 1659 39C1585 39 1524 126 1540 220C1552 219 1740 222 1767 222Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g><g transform="matrix(1,0,0,1,77.83746337890625,27.399993896484375)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M949 272L743 486L711 452L836 300L65 300L65 241L836 241L711 89L743 55Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g></g><g><g transform="matrix(1,0,0,1,98.46246337890625,27.399993896484375)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M294 284C294 90 401 -18 592 -18C688 -18 759 5 849 67C849 67 859 103 859 103C859 103 849 110 849 110C755 53 703 35 625 35C468 35 382 131 382 309C382 447 439 653 667 653C738 653 790 639 846 603L846 519L873 519C878 576 886 619 900 665C824 694 767 706 705 706C525 706 294 578 294 284Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,123.71246337890625,27.399993896484375)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M604 347L604 406L65 406L65 347ZM604 134L604 193L65 193L65 134Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,140.17498779296875,27.399993896484375)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g><g><g><g transform="matrix(1,0,0,1,149.26251220703125,15)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M400 -16C446 -16 513 54 545 84L545 97L532 97C513 79 489 55 462 55C417 55 424 184 424 216C474 278 520 343 558 413C551 428 544 444 536 459L525 459C511 391 456 315 420 257C422 336 445 472 332 473C164 473 27 243 24 93C23 33 43 -16 111 -16C203 -16 297 64 357 131C357 96 348 -15 400 -16ZM284 437C371 437 358 224 357 164C314 113 233 28 162 28C109 28 98 70 99 115C100 202 175 437 284 437Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g></g></g><g><g><g><g transform="matrix(1,0,0,1,146.11248779296875,40.79998779296875)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M483 722L471 733C419 707 383 698 311 691L307 670L355 670C379 670 389 663 389 646C389 638 388 629 387 622L359 468C329 477 302 482 277 482C208 482 114 410 68 323C37 265 17 170 17 86C17 21 32 -11 61 -11C88 -11 125 6 159 33C213 77 246 116 313 217L290 126C279 82 274 50 274 24C274 3 283 -9 300 -9C317 -9 341 3 375 28L456 88L446 107L402 76C388 66 372 59 363 59C355 59 349 68 349 82C349 90 350 99 357 128ZM114 59C98 59 89 73 89 98C89 224 135 380 184 418C197 428 216 433 243 433C287 433 316 427 349 410L337 351C300 171 159 59 114 59ZM831 222C841 251 847 268 846 263C767 261 690 262 612 262C631 349 686 438 786 438C846 438 868 420 895 369L915 369L956 422C781 592 512 361 512 155C512 42 578 -11 685 -11C762 -11 826 47 885 92L885 111C838 78 782 39 723 39C649 39 588 126 604 220C616 219 804 222 831 222Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g></g></g><line style="fill:none;stroke-width:1px;stroke:rgb(0, 0, 0);" x1="146.11248779296875" y1="22.95001220703125" x2="162.51248741149902" y2="22.95001220703125"></line></g></g></g></svg>
                            </div>
                        </div><br>

                        This, however, is not enough to determine blood oxygen saturation (SaO2). Beer-Lambert‚Äôs law will determine the concentration of oxyhemoglobin within the volume of blood contained within the finger, but that is unhelpful, as the figure that is important in this case is the proportion of oxyhemoglobin as compared to all hemoglobin in the blood.<sup><a href="works-cited.html#14">[14]</a></sup> Therefore, our pulse oximeter will have to use two lights at different wavelengths, repeating Beer-Lambert‚Äôs law for each; one being to determine the concentration of oxyhemoglobin in the blood, the other being to determine the concentration of deoxyhemoglobin in the blood. Following that, it‚Äôs a simple task of dividing total hemoglobin (Hb + O2Hb) by oxygenated hemoglobin (O2Hb) and then multiplying the result by 100 to obtain a human-readable percentage, as in the formula shown below<sup><a href="works-cited.html#14">[14]</a></sup> (SpO2 being the SaO2 reading returned by the oximeter). <br>
                        
                        <div class="formula-container">
                            <svg class="formula" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" width="231.8000373840332" height="54.17499923706055" style="width:231.8000373840332px;height:54.17499923706055px;font-family:Asana-Math, Asana;background:#FFF;"><g><g><g><g transform="matrix(1,0,0,1,2,33.38749694824219)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M108 471C108 386 146 339 230 319L325 296C379 283 406 248 406 191C406 96 335 30 232 30C178 30 140 42 96 73L96 172L66 172C60 117 53 72 42 20C91 -5 144 -18 197 -18C352 -18 485 99 485 234C485 313 442 355 341 377L276 391C210 405 180 442 180 508C180 595 247 658 339 658C388 658 421 645 451 613L451 537L481 537C485 591 492 629 506 672C461 696 421 706 374 706C250 706 108 614 108 471ZM731 -11C787 -11 902 62 945 125C986 186 1020 296 1020 371C1020 438 997 482 961 482C919 482 866 456 814 409C773 374 753 348 717 289L741 408C744 425 746 440 746 452C746 471 738 482 724 482C703 482 665 461 591 408L563 388L570 368L602 389C630 407 641 412 650 412C660 412 667 403 667 389C667 381 665 361 663 351L605 8C595 -52 576 -143 556 -233L548 -270L555 -276C576 -269 596 -264 628 -259L670 3C691 -4 713 -11 731 -11ZM698 165C720 293 827 424 910 424C936 424 948 402 948 356C948 275 908 156 855 80C835 51 803 36 762 36C731 36 706 43 680 59ZM1802 425C1802 603 1698 706 1518 706C1281 706 1107 523 1107 272C1107 83 1201 -18 1377 -18C1649 -18 1802 207 1802 425ZM1714 409C1714 221 1625 24 1414 24C1270 24 1195 110 1195 277C1195 425 1253 664 1487 664C1603 664 1714 610 1714 409Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g><g><g><g transform="matrix(1,0,0,1,33.63751220703125,36.4)"><path transform="matrix(0.0119,0,0,-0.0119,0,0)" d="M16 23L16 -3C203 -3 203 0 239 0C275 0 275 -3 468 -3L468 82C353 77 307 81 122 77L304 270C401 373 431 428 431 503C431 618 353 689 226 689C154 689 105 669 56 619L39 483L68 483L81 529C97 587 133 612 200 612C286 612 341 558 341 473C341 398 299 324 186 204Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g></g></g></g><g><g transform="matrix(1,0,0,1,40.5875244140625,33.38749694824219)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,49.925048828125,33.38749694824219)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M604 347L604 406L65 406L65 347ZM604 134L604 193L65 193L65 134Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,66.38751220703125,33.38749694824219)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g><g><g><g transform="matrix(1,0,0,1,72.32501220703125,19)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M221 385L263 613C270 652 277 658 314 661L356 664L359 692L335 692L245 689C229 689 211 689 168 690L104 692L101 664L148 662C172 661 183 653 183 635C183 621 179 590 174 559L100 125C83 33 82 32 42 28L1 25L-3 -3L39 -2C87 -1 110 0 129 0L226 -3L252 -3L255 25L206 28C179 30 170 37 170 58C170 67 171 74 174 93L216 340L277 341C339 342 381 343 400 343C419 343 460 342 523 341L584 340L544 125C535 76 528 48 523 42C519 34 508 30 486 28L436 25L432 -3L488 -2C532 -1 562 0 573 0C589 0 620 -1 663 -2L705 -3L708 25L650 28C624 29 614 37 614 58C614 67 615 76 618 93L710 613C717 652 723 657 761 661L797 664L800 692L784 692L693 689C678 689 657 689 613 690L550 692L547 664L595 662C619 661 630 653 630 635C630 621 626 589 621 559L591 385ZM1012 722L1000 733C948 707 912 698 840 691L836 670L884 670C908 670 918 663 918 646C918 639 917 628 916 622L815 71C814 68 814 64 814 61C814 22 862 -11 917 -11C954 -11 1005 8 1048 39C1144 107 1210 244 1210 376C1210 414 1201 453 1189 468C1182 477 1169 482 1154 482C1130 482 1100 474 1072 460C1021 433 988 403 926 324ZM1099 424C1125 424 1138 401 1138 352C1138 288 1117 202 1087 137C1054 68 1014 36 960 36C914 36 889 59 889 101C889 135 904 276 985 361C1018 395 1070 424 1099 424ZM1987 425C1987 603 1883 706 1703 706C1466 706 1292 523 1292 272C1292 83 1386 -18 1562 -18C1834 -18 1987 207 1987 425ZM1899 409C1899 221 1810 24 1599 24C1455 24 1380 110 1380 277C1380 425 1438 664 1672 664C1788 664 1899 610 1899 409Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g><g><g><g transform="matrix(1,0,0,1,107.10003662109375,22.01250305175781)"><path transform="matrix(0.0119,0,0,-0.0119,0,0)" d="M16 23L16 -3C203 -3 203 0 239 0C275 0 275 -3 468 -3L468 82C353 77 307 81 122 77L304 270C401 373 431 428 431 503C431 618 353 689 226 689C154 689 105 669 56 619L39 483L68 483L81 529C97 587 133 612 200 612C286 612 341 558 341 473C341 398 299 324 186 204Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g></g></g></g><g><g transform="matrix(1,0,0,1,114.050048828125,19)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,121.6875,19)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M604 241L604 300L364 300L364 538L305 538L305 300L65 300L65 241L305 241L305 0L364 0L364 241Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,136.45001220703125,19)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M470 385L512 613C519 652 526 658 563 661L605 664L608 692L584 692L494 689C478 689 460 689 417 690L353 692L350 664L397 662C421 661 432 653 432 635C432 621 428 590 423 559L349 125C332 33 331 32 291 28L250 25L246 -3L288 -2C336 -1 359 0 378 0L475 -3L501 -3L504 25L455 28C428 30 419 37 419 58C419 67 420 74 423 93L465 340L526 341C588 342 630 343 649 343C668 343 709 342 772 341L833 340L793 125C784 76 777 48 772 42C768 34 757 30 735 28L685 25L681 -3L737 -2C781 -1 811 0 822 0C838 0 869 -1 912 -2L954 -3L957 25L899 28C873 29 863 37 863 58C863 67 864 76 867 93L959 613C966 652 972 657 1010 661L1046 664L1049 692L1033 692L942 689C927 689 906 689 862 690L799 692L796 664L844 662C868 661 879 653 879 635C879 621 875 589 870 559L840 385ZM1261 722L1249 733C1197 707 1161 698 1089 691L1085 670L1133 670C1157 670 1167 663 1167 646C1167 639 1166 628 1165 622L1064 71C1063 68 1063 64 1063 61C1063 22 1111 -11 1166 -11C1203 -11 1254 8 1297 39C1393 107 1459 244 1459 376C1459 414 1450 453 1438 468C1431 477 1418 482 1403 482C1379 482 1349 474 1321 460C1270 433 1237 403 1175 324ZM1348 424C1374 424 1387 401 1387 352C1387 288 1366 202 1336 137C1303 68 1263 36 1209 36C1163 36 1138 59 1138 101C1138 135 1153 276 1234 361C1267 395 1319 424 1348 424Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g></g></g><g><g><g><g transform="matrix(1,0,0,1,96.175048828125,46.78749084472656)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M221 385L263 613C270 652 277 658 314 661L356 664L359 692L335 692L245 689C229 689 211 689 168 690L104 692L101 664L148 662C172 661 183 653 183 635C183 621 179 590 174 559L100 125C83 33 82 32 42 28L1 25L-3 -3L39 -2C87 -1 110 0 129 0L226 -3L252 -3L255 25L206 28C179 30 170 37 170 58C170 67 171 74 174 93L216 340L277 341C339 342 381 343 400 343C419 343 460 342 523 341L584 340L544 125C535 76 528 48 523 42C519 34 508 30 486 28L436 25L432 -3L488 -2C532 -1 562 0 573 0C589 0 620 -1 663 -2L705 -3L708 25L650 28C624 29 614 37 614 58C614 67 615 76 618 93L710 613C717 652 723 657 761 661L797 664L800 692L784 692L693 689C678 689 657 689 613 690L550 692L547 664L595 662C619 661 630 653 630 635C630 621 626 589 621 559L591 385ZM1012 722L1000 733C948 707 912 698 840 691L836 670L884 670C908 670 918 663 918 646C918 639 917 628 916 622L815 71C814 68 814 64 814 61C814 22 862 -11 917 -11C954 -11 1005 8 1048 39C1144 107 1210 244 1210 376C1210 414 1201 453 1189 468C1182 477 1169 482 1154 482C1130 482 1100 474 1072 460C1021 433 988 403 926 324ZM1099 424C1125 424 1138 401 1138 352C1138 288 1117 202 1087 137C1054 68 1014 36 960 36C914 36 889 59 889 101C889 135 904 276 985 361C1018 395 1070 424 1099 424ZM1987 425C1987 603 1883 706 1703 706C1466 706 1292 523 1292 272C1292 83 1386 -18 1562 -18C1834 -18 1987 207 1987 425ZM1899 409C1899 221 1810 24 1599 24C1455 24 1380 110 1380 277C1380 425 1438 664 1672 664C1788 664 1899 610 1899 409Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g><g><g><g transform="matrix(1,0,0,1,130.95001220703125,49.799993896484374)"><path transform="matrix(0.0119,0,0,-0.0119,0,0)" d="M16 23L16 -3C203 -3 203 0 239 0C275 0 275 -3 468 -3L468 82C353 77 307 81 122 77L304 270C401 373 431 428 431 503C431 618 353 689 226 689C154 689 105 669 56 619L39 483L68 483L81 529C97 587 133 612 200 612C286 612 341 558 341 473C341 398 299 324 186 204Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g></g></g></g></g></g><line style="fill:none;stroke-width:1px;stroke:rgb(0, 0, 0);" x1="72.32501220703125" y1="28.9375" x2="161.75001525878906" y2="28.9375"></line></g><g><g transform="matrix(1,0,0,1,163.45001220703125,33.38749694824219)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,171.0875244140625,33.38749694824219)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M611 37L376 271L611 505L568 547L335 313L101 547L59 505L293 271L59 37L101 -5L335 229L568 -5Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g><g><g transform="matrix(1,0,0,1,185.85003662109375,33.38749694824219)"><path transform="matrix(0.017,0,0,-0.017,0,0)" d="M667 -3L667 27L615 30C560 33 550 44 550 96L550 700L309 598L316 548L466 614L466 96C466 44 455 33 401 30L345 27L345 -3C499 0 499 0 510 0C541 0 651 -3 667 -3ZM1011 689C856 689 777 566 777 324C777 207 798 106 833 57C868 8 924 -20 986 -20C1137 -20 1213 110 1213 366C1213 585 1148 689 1011 689ZM993 654C1090 654 1129 556 1129 316C1129 103 1091 15 999 15C902 15 861 116 861 360C861 571 898 654 993 654ZM1510 689C1355 689 1276 566 1276 324C1276 207 1297 106 1332 57C1367 8 1423 -20 1485 -20C1636 -20 1712 110 1712 366C1712 585 1647 689 1510 689ZM1492 654C1589 654 1628 556 1628 316C1628 103 1590 15 1498 15C1401 15 1360 116 1360 360C1360 571 1397 654 1492 654ZM1949 689C1854 689 1785 619 1785 522C1785 433 1850 368 1939 368C2032 368 2101 439 2101 535C2101 623 2036 689 1949 689ZM1946 666C1997 666 2029 615 2029 533C2029 447 1994 391 1940 391C1887 391 1857 440 1857 526C1857 612 1891 666 1946 666ZM2396 321C2301 321 2232 251 2232 154C2232 65 2297 0 2386 0C2479 0 2548 71 2548 167C2548 255 2483 321 2396 321ZM2393 298C2444 298 2476 247 2476 165C2476 79 2441 23 2387 23C2334 23 2304 72 2304 158C2304 244 2338 298 2393 298ZM1996 -20L2362 709L2322 709L1956 -20Z" stroke="rgb(0,0,0)" stroke-opacity="1" stroke-width="8" fill="rgb(0,0,0)" fill-opacity="1"></path></g></g></g></g></svg>
                        </div><br>

                        The reason this works is that oxyhemoglobin has a slightly different absorption spectrum than deoxyhemoglobin.<sup><a href="works-cited.html#18">[18]</a></sup> In layman‚Äôs terms, this means that it has a slightly different color; though nothing nearly as drastic as the popular perception that deoxygenated blood is blue. This difference is illustrated on the graph below. The red line represents the absorption spectrum of oxyhemoglobin (HbO2), and the blue represents the absorption spectrum of deoxyhemoglobin (Hb). On the lower end of the spectrum, around the 660 nm wavelength of light that is typically used, which is visible red light, deoxyhemoglobin absorbs much more light. However, on the higher end of the scale, around the 940 nm wavelength, which is infrared light, oxyhemoglobin absorbs much more light. This allows us to effectively isolate the types of hemoglobin from each other by using wavelengths of light on either end of the absorption spectrum.<br>
                        
                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/hemoglobin-absorption-spectra-near-infrared.png" alt="A graph from a 1988 patent filing for a pulse oximeter. It is awful and very confusing."><br>
                                <figcaption class="figure-caption">A graph of the absorption spectra of oxyhemoglobin and deoxyhemoglobin<br>in the near-infrared band of light.</figcaption>
                            </figure>
                        </div><br>

                        However, we are once again not finished. The important reading is arterial oxygen saturation, since veins are completely expected to contain nearly all deoxygenated blood.<sup><a href="works-cited.html#22">[22]</a></sup> Therefore, not only does the oximeter have to isolate the types of hemoglobin from each other, it also has to isolate the parts of the reading that come from arteries from those that come from veins. This is accomplished by the fact that arteries pulsate with the heartbeat, while veins (by and large) do not.<sup><a href="works-cited.html#21">[21]</a></sup> Therefore, the device can isolate the parts of the reading which are pulsating and only use those<sup><a href="works-cited.html#22">[22]</a></sup> - this is where the ‚Äúpulse‚Äù part of pulse oximeter comes from. A side effect of this method is that pulse oximeters, by their nature, also measure heart rate. 

                        Despite its incredibly clever design, pulse oximeters do have a few flaws, most notably in cases in which they simply will not give accurate results. These are in cases of carbon monoxide poisoning and of methemoglobinemia. Carbon monoxide poisoning causes issues because carbon monoxide (CO) binds readily to hemoglobin, creating carboxyhemoglobin, which has a very similar emissions spectrum to oxyhemoglobin at the 660 nm where it is typically measured. This means that CO can effectively mask its presence to the oximeter, presenting as normal oxygen and giving a dangerously misleading impression of the reading.<sup><a href="works-cited.html#14">[14, 16]</a></sup> The other misleading result that pulse oximeters tend to give is in patients with a type of anemia called methemoglobinemia. Methemoglobin is a form of hemoglobin that cannot carry oxygen, meaning that blood full of methemoglobin will not be able to carry oxygen to the body‚Äôs tissues. This is, of course, very dangerous. However, because of methemoglobin‚Äôs substantial absorption spectrum on both the 940 and 660 nm wavelengths of light used in most traditional pulse oximeters, when it is in concentrations at or above about 30% it causes the oximeter to incorrectly read near 85% regardless of the patient‚Äôs true saturation.<sup><a href="works-cited.html#14">[14, 16, 17, 20]</a></sup><br>

                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/absorbance-spectra-with-COHb-and-MetHb.png" alt="A graph from a 1988 patent filing for a pulse oximeter. It is awful and very confusing."><br>
                                <figcaption class="figure-caption">A graph of the absorption spectra of oxyhemoglobin, deoxyhemoglobin,<br>carboxyhemoglobin, and methemoglobin in the near-infrared band of light.</figcaption>
                            </figure>
                        </div><br>

                        There exist oximeters which get around these issues by using more wavelengths of light; with more reference points, in some cases as many as 8,<sup><a href="works-cited.html#16">[16]</a></sup> it becomes possible to isolate methemoglobin and carboxyhemoglobin in the reading and overcome these limitations. However, methemoglobinemia is very rare and carbon monoxide poisoning is only a risk in very specific circumstances; for instance, if someone presents to a hospital emergency room, there is little point to screening them for carbon monoxide poisoning, since being away from the source of the carbon monoxide and in fresh air will in almost all circumstances cause their symptoms to dissipate. For that reason, most pulse oximeters in use today continue to have these limitations. 

                        <br><br>That's all for now. I'll be back at some point with yet another dive into pulse oximetry, though hopefully a bit less dense this time. <br><br>

                        See you next time,<br><br>

                        Luca.
                    </p>
                    <hr>
                </article>

                <article class="research-notes technology">
                    <div class="img-wrap">
                        <img class="article-image rounded" src="Assets/pulse-oximeter-doctor.jpg" alt="An image of a doctor using a pulse oximeter device on a patient.">
                    </div>
                    <h1 class="title">Research Notes 1: Intro to the Research Notes Format and Pulse Oximeters</h1>
                    <h6 class="date">15th of October, 2022</h6>
                    <h4 id="name">Luca Donais</h4>
                    <p style="margin-top: 3vh;">
                        If you‚Äôve ever been to a hospital emergency room, you‚Äôve probably had one of these little doodads clipped onto your finger. As a child, I ended up in the hospital quite a lot, and was never quite sure what they were for. At the time, I never bothered to ask; but having been back in the hospital a few times in the last year or so, my childhood curiosity came back to me. This time though, I had the advantage of the internet and the ability to read patent filings. And also the lack of self-respect required to be willing to read very dense patent filings with graphs that look like this.<sup><a href="works-cited.html#13">[13]</a></sup> Joy!

                        <div class="img-wrap">
                            <figure class="figure">
                                <br><img class="article-image rounded" src="Assets/patent-graph1.png" alt="A graph from a 1988 patent filing for a pulse oximeter. It is awful and very confusing."><br>
                                <figcaption class="figure-caption">A graph from a 1988 patent filing for a pulse oximeter.</figcaption>
                            </figure>
                        </div>

                        To google it was, then. Cursory research told me that these are called pulse oximeters, and that they are sensors that measure the oxygen saturation in your blood.<sup><a href="works-cited.html#14">[14]</a></sup> That threw me for a loop a little bit. Blood lives inside the body, and so to measure most things about it, you need to remove some and analyze it in a lab. However, pulse oximeters dispense with all that unpleasantness, giving an at-a-glance view of respiratory system function within seconds. That is an incredible tool, but also seems to break just about all of the rules. How is it possible for that to work?<br><br>

                        Well, I‚Äôm going to deal with that next time. This post is an introduction to the ‚ÄúResearch Notes‚Äù format, which will be a little shorter and less formal, and will be more focused on diving into topics that interest me or that are relevant to coursework. It will be a place for me to organize my thoughts and dump some sources, as well as a place to talk about things that interest me!<br><br>

                        See you next time,<br><br>

                        Luca.<br><br>

                    </p>
                    <hr>
                </article>

            <article class="technology policy course-required">
                <div class="img-wrap">
                    <img class="article-image rounded" src="Assets/Traffic-image.jpg" alt="An image of heavy traffic, taken from a view slightly angled downward.">
                </div>
                <h1 class="title">California Bans Sales of Fossil-Fuel-Burning Cars by 2035</h1>
                <h6 class="date">12th of October, 2022</h6>
                <h4 id="name">Luca Donais</h4>
                <p style="margin-top: 3vh;">
                    Today, I read an article by Naveena Sadasivam in Grist Magazine titled ‚ÄúIt‚Äôs official: California is phasing out gas-powered cars by 2035‚Äù<sup><a href="works-cited.html#8">[8]</a></sup>. The article was fascinating, and it brought up a number of interesting policy questions around health, climate, and other major issues in the world today. The policy is built on an executive order<sup><a href="works-cited.html#4">[4]</a></sup> passed by California governor Gavin Newsom. To be quite honest, as a serious piece of policy, I find the executive order and what has been built around it rather lackluster. While it is true that electric vehicles (EVs) are an important tool in combating climate change, they are not in and of themselves a solution. There are a whole raft of environmental, social, and health issues that EVs are either not equipped to address, or that they will actively worsen. <br><br>

                    My biggest gripe with this policy is that the solution remains car-centric, with little recognition of the very real harms that personal automobiles cause to individuals and society. Cars are an extremely inefficient mode of transportation, both in terms of space efficiency within cities<sup><a href="works-cited.html#6">[6]</a></sup> and in terms of energy efficiency<sup><a href="works-cited.html#11">[11]</a></sup>, as compared to high-occupancy vehicles like buses and especially trains. In addition, public transportation has shown benefits in increasing social mobility<sup><a href="works-cited.html#1">[1]</a></sup>, increasing the general health of those who take it through increased physical activity, and thus, reducing healthcare costs to society<sup><a href="works-cited.html#9">[9]</a></sup>, and other benefits. In addition, public transit is also significantly safer than personal cars. Per-kilometer, you‚Äôre about 17 times more likely to die in a car than on a train, and about 100 times more likely to die in a car than on an airplane. In the US, about 80 people die in cars every day, all in service of a mode of transit that is less efficient and more dangerous than the alternatives.<sup><a href="works-cited.html#10">[10]</a></sup>
                    
                    <div class="img-wrap">
                        <figure class="figure">
                            <br><img class="article-image rounded" src="Assets/tesla.jpg" alt="A destroyed tesla after a crash. It is on fire."><br>
                            <figcaption class="figure-caption">A tesla after a crash.</figcaption>
                        </figure>
                    </div>

                    There are also environmental concerns around EVs that should not be dismissed. While their environmental benefit, by taking gas-powered vehicles off the road and thus removing emissions, is clear, so is their environmental detriment. The mining of the various materials needed to manufacture electric cars, particularly lithium and cobalt, is environmentally ruinous. Lithium mining alone requires vast amounts of water; one proposed mine in the United States is expected to use billions of gallons of it ‚Äî 14 356 liters per minute, some of which may remain contaminated for as many as 300 years<sup><a href="works-cited.html#5">[5]</a></sup>. The mines also create enormous quantities of chemical waste and destroy animal habitats, all at great expense to taxpayers in the form of mining subsidies and grants.<br><br>
                    
                    
                    <div class="img-wrap">
                        <figure class="figure">
                            <br><img class="article-image rounded" src="Assets/lithium-mine.webp" alt="An image of an open-pit lithium mine from above."><br>
                            <figcaption class="figure-caption">A lithium mine.</figcaption>
                        </figure>
                    </div>

                    With all this talk of environmental and urban policy, we‚Äôve largely ignored the other major topic of this blog, which is health. The article correctly points out that there are major health benefits to reducing greenhouse gas emissions and smog in cities, which contribute significantly to various respiratory and circulatory illnesses like asthma and heart disease<sup><a href="works-cited.html#8">[8, 12]</a></sup>. However, there are some hidden assumptions in this assessment that I believe are worth interrogating.<br><br>
                    
                    Mining for cobalt, an essential component in EV production, happens mostly in the Democratic Republic of the Congo (DRC), which produces about 60% of the world‚Äôs cobalt<sup><a href="works-cited.html#3">[3]</a></sup>. For context, the DRC is a country with about 3% of Canada‚Äôs GDP (despite having well over twice our population), and about 0.24% of the United States‚Äô GDP. The mining of cobalt is horrible for the environment, and almost as bad for the health of the miners. In an ironic twist, it produces significant and toxic air pollution, which can cause asthma and pneumonia, among other respiratory issues. Some particles emitted in cobalt mining are radioactive or cancer-causing, and have been known to cause cancer, vision problems, and thyroid problems<sup><a href="works-cited.html#3">[3]</a></sup>. It also has wider social impacts; cobalt mining in the DRC has been linked to increased violence, substance abuse, food and water insecurity, loss of communal land, farmland, and homes, mental health challenges, and other detrimental impacts.<sup><a href="works-cited.html#7">[7]</a></sup> While the health benefits of reducing pollution are self-evidently good things, this policy and others focused on electric vehicles simply export our health and social issues into places where people are too stricken with poverty to argue, in service of reducing the climate guilt of those who are already wealthy.<br><br>
                    
                    In the end, this is probably a step in the right direction. However, there are a million better ways to step in this direction, many of which are less counterproductive to the policy‚Äôs stated goals. Like building a train. I‚Äôd even settle for some buses. Please.<br>                       
                </p>
                <hr>
            </article>

            </div>
            <div class="col-3"></div>
        </div>

        <!-- jQuery -->
        <script src="libraries/jquery-3.6.1.min.js"></script>
        <!-- Main script -->
        <script src="script.js"></script>
    </body>
</html>
